Magnet calibration by the floating-wire method /

Work performed at the Los Alamos Scientific Laboratory." November 23, 1951 [TIS Issuance Date]""AECU-1670."Mode of access: Internet

An overview of the national uranium resource evaluation hydrogeochemical and stream sediment reconnaissance program /

"UC-51.""Isssued: July 1980."Mode of access: Internet

Current radiochemical research at Los Alamos : proposed talk to be given at Brookhaven National Laboratory /

Work performed at the Los Alamos Scientific Laboratory."Revised: June 14, 1949.""Date Declassified: June 6, 1949.""AECD-2625; (LADC-677)".Mode of access: Internet

Associated convex bodies /

Work performed at the Los Alamos Scientific Laboratory."September 25, 1951, [TIS Issuance Date]"Mode of access: Internet

Computer program for universal transverse Mercator map projection /

"Issued: August 1977.""LA-6902-MS."United States Energy Research and Development Administration contract :Mode of access: Internet

A highly effective catalyst for the ortho-to-para hydrogen conversion /

Work performed at the Los Alamos Scientific Laboratory."November 1952, [TIS Issuance Date]"Mode of access: Internet

Preparation of a standard sample of C¹⁴ labeled benzoic acid for efficiency determinations in scintillation counting /

Work performed at the Los Alamos Scientific Laboratory." July 1953, [TIS Issuance Date]"Mode of access: Internet

Metabolism of plutonium in the rat / by Wright H. Langham.

This report gives a comprehensive summary of the project literature dealing with the absorption, excretion, and body deposition of plutonium when administered in various forms and by various routes to the rat. Additional experimental data are presented regarding the metabolism of plutonium when administered to the rat by intravenous injection. The results indicated the following: (1) The first day following intravenous injection of PuO2(NO3)2, the urinary excretion of plutonium was 7.5 per cent of the dose as compared to 0.33, 0.57, and 0.71 per cent when administered as PuCl3, Pu(NO3)4, and Pu+4 citrate complex, respectively. Fecal excretion during the first day was correspondingly lower following injection of PuO2(N03)2. On the thirtieth day following intravenous injection there were no significant differences in either urinary or fecal excretion of plutonium administered as PuCl3, Pu(NO3)4, Pu+4 citrate complex, and PuO2(NO3)2. At this time the average urinary excretion was 0.014 per cent of the injected dose and the average fecal excretion was 0.22 per cent. The average ratio of fecal to urinary excretion was 16/1. Urinary and fecal excretion curves are given for all forms of plutonium injected. (2) The skeleton was the principal site of deposition regardless of the form in which the plutonium was injected. Four days following injection of plutonium as PuCl3, Pu(NO3)4, Pu+4 citrate complex, and PuO2(NO3)2 skeletal deposition was 44.9, 29.3, 56.9, and 56.5 per cent of the injected dose, respectively. Deposition in the liver under the above conditions was 22.9, 39.7, 9.6, and 9.1 per cent of the injected dose, respectively. Deposition of plutonium in kidney, spleen, and in 'balance' was not greatly affected by the form in which the plutonium was administered.Work performed at the Los Alamos Scientific Laboratory."Date Declassified: April 1, 1948.""LADC-472."This report gives a comprehensive summary of the project literature dealing with the absorption, excretion, and body deposition of plutonium when administered in various forms and by various routes to the rat. Additional experimental data are presented regarding the metabolism of plutonium when administered to the rat by intravenous injection. The results indicated the following: (1) The first day following intravenous injection of PuO2(NO3)2, the urinary excretion of plutonium was 7.5 per cent of the dose as compared to 0.33, 0.57, and 0.71 per cent when administered as PuCl3, Pu(NO3)4, and Pu+4 citrate complex, respectively. Fecal excretion during the first day was correspondingly lower following injection of PuO2(N03)2. On the thirtieth day following intravenous injection there were no significant differences in either urinary or fecal excretion of plutonium administered as PuCl3, Pu(NO3)4, Pu+4 citrate complex, and PuO2(NO3)2. At this time the average urinary excretion was 0.014 per cent of the injected dose and the average fecal excretion was 0.22 per cent. The average ratio of fecal to urinary excretion was 16/1. Urinary and fecal excretion curves are given for all forms of plutonium injected. (2) The skeleton was the principal site of deposition regardless of the form in which the plutonium was injected. Four days following injection of plutonium as PuCl3, Pu(NO3)4, Pu+4 citrate complex, and PuO2(NO3)2 skeletal deposition was 44.9, 29.3, 56.9, and 56.5 per cent of the injected dose, respectively. Deposition in the liver under the above conditions was 22.9, 39.7, 9.6, and 9.1 per cent of the injected dose, respectively. Deposition of plutonium in kidney, spleen, and in 'balance' was not greatly affected by the form in which the plutonium was administered.Mode of access: Internet

Strain specificity of the therapeutic effect of splenic transplants in irradiated mice /

Work performed at the Los Alamos Scientific Laboratory."August 1952, [TIS Issuance Date]"Mode of access: Internet

Water boiler /

Date of Manuscript: UnknownManhattan District Declassified CodeMode of access: Internet